BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12458889)

  • 1. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S; Kocer I; Memisogullari R; Kiziltunc A
    Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet's disease with and without ocular disease.
    Aydin E; Sögüt S; Ozyurt H; Ozugurlu F; Akyol O
    Ophthalmic Res; 2004; 36(3):177-82. PubMed ID: 15103210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sister chromatid exchange and micronucleus studies in patients with Behçet's disease.
    Karaman A; Kadi M; Kara F
    J Cutan Pathol; 2009 Aug; 36(8):831-7. PubMed ID: 19159395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress: correlation with Behçet's disease duration, activity and severity.
    Harzallah O; Kerkeni A; Baati T; Mahjoub S
    Eur J Intern Med; 2008 Nov; 19(7):541-7. PubMed ID: 19013385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte antioxidant activity and trace element levels in Behçet's disease.
    Tüzün A; Aydin A; Turan M
    Biol Trace Elem Res; 1998; 64(1-3):169-74. PubMed ID: 9845471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidant/antioxidant status in men with Behçet's disease.
    Taysi S; Demircan B; Akdeniz N; Atasoy M; Sari RA
    Clin Rheumatol; 2007 Mar; 26(3):418-22. PubMed ID: 17206395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trace elements and antioxidant enzymes in Behçet's disease.
    Saglam K; Serce AF; Yilmaz MI; Bulucu F; Aydin A; Akay C; Sayal A
    Rheumatol Int; 2002 Jul; 22(3):93-6. PubMed ID: 12111082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
    Sarban S; Kocyigit A; Yazar M; Isikan UE
    Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
    Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
    Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of antioxidant defence system and lipid peroxidation in peripheral blood of female patients with chronic idiopathic urticaria.
    Kasperska-Zajac A; Brzoza Z; Polaniak R; Rogala B; Birkner E
    Arch Dermatol Res; 2007 Mar; 298(10):499-503. PubMed ID: 17171548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of serum selenium, zinc, copper, and iron concentrations and some related antioxidant enzyme activities in patients with cutaneous leishmaniasis.
    Kocyigit A; Erel O; Gurel MS; Avci S; Aktepe N
    Biol Trace Elem Res; 1998 Dec; 65(3):271-81. PubMed ID: 9892499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease.
    Polat MF; Taysi S; Gul M; Cikman O; Yilmaz I; Bakan E; Erdogan F
    Cell Biochem Funct; 2002 Dec; 20(4):327-31. PubMed ID: 12415567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nitrosative and oxidative stress in Behçet disease.
    Bekpinar S; Kiliç N; Unlüçerçi Y; Akdag-Köse A; Azizlerli G; Ozbek-Kir Z
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):167-71. PubMed ID: 15752284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis.
    Serarslan G; Yilmaz HR; Söğüt S
    Clin Exp Dermatol; 2005 May; 30(3):267-71. PubMed ID: 15807687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
    Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.